<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04343638</url>
  </required_header>
  <id_info>
    <org_study_id>4-2020-0130</org_study_id>
    <nct_id>NCT04343638</nct_id>
  </id_info>
  <brief_title>Effect of Intraoperative Nociception Control Based on Analgesia Nociception Index (ANI) Monitoring on Stress Response During Total Laparoscopic Hysterectomy</brief_title>
  <official_title>Effect of Intraoperative Nociception Control Based on Analgesia Nociception Index (ANI) Monitoring on Stress Response During Total Laparoscopic Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The &quot;Analgesia Nociception Index&quot; (ANI; MetroDoloris Medical Systems, Lille, France), derived&#xD;
      from an electrocardiogram (ECG) trace, has been proposed as a noninvasive guide to analgesia.&#xD;
      The ANI monitor calculates HR variation with respiration, a response mediated primarily by&#xD;
      changes in the parasympathetic nervous system (PNS) stimulation to the sinoatrial node of the&#xD;
      heart. The aim of this study is to determine the relation between ANI monitor values and&#xD;
      serum catecholamine levels. We will compare the serum catecholamine (norepinephrine,&#xD;
      epinephrine) levels of conventional nociception control group and ANI-monitor guided&#xD;
      nociception control group at the end of surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 8, 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The subject will be randomly allocated to 2 groups using computer-generated randomization method. Anesthesiologists will not be blinded to the groups because of organizational reasons.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Serum catecholamine (norepinephrine, epinephrine) level at the end of surgery</measure>
    <time_frame>at the end of surgery (skin closure)</time_frame>
    <description>Blood samples for serum catecholamine (norepinephrine, epinephrine) will be drawn at the end of surgery and 1 hour after the end of surgery..</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasma inflammatory markers (IL-6, IL-10, HMGB1)</measure>
    <time_frame>at the end of surgery (skin closure) and 1 hour after the end of surgery</time_frame>
    <description>Blood samples for plasma inflammatory markers (IL-6, IL-10, HMGB1) will be drawn at the end of surgery (skin closure) and 1 hour after the end of surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hormone level (cortisol, adrenocorticotropic hormone)</measure>
    <time_frame>at the end of surgery (skin closure) and 1 hour after the end of surgery</time_frame>
    <description>blood samples for hormone levels (cortisol, adrenocorticotropic hormone) will be drawn at the end of surgery (skin closure) and 1 hour after the end of surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum catecholamine (norepinephrine, epinephrine) level</measure>
    <time_frame>1 hour after the surgery</time_frame>
    <description>Blood samples for serum catecholamine (norepinephrine, epinephrine) will be drawn 1hour after surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Patients Undergoing Total Laparoscopic Hysterectomy</condition>
  <arm_group>
    <arm_group_label>conventional nociception control arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intraoperative opioid will be administered by conventional clinical practice. ANI monitor readings will not be visible to the anesthesiologist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ANI-monitor guided nociception control arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intraoperative opioid will be administered by maintaining the 4-minute moving average of ANI ≥50.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>conventional nociception control</intervention_name>
    <description>While Intraoperative opioid will be administered by conventional clinical practice in control arm.</description>
    <arm_group_label>conventional nociception control arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ANI monitor guided nociception control</intervention_name>
    <description>The intraoperative opioid will be administered by maintaining the 4-minute moving average of ANI ≥50 in ANI-monitor guided nociception control arm.</description>
    <arm_group_label>ANI-monitor guided nociception control arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1. patients undergoing total laparoscopic hysterectomy under general anesthesia (American&#xD;
        society of anesthesiologists classification 1~3)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. endometriosis&#xD;
&#xD;
          2. AP diameter of uterus &gt; 12cm&#xD;
&#xD;
          3. cognitive disorder&#xD;
&#xD;
          4. arrhythmia, pacemaker&#xD;
&#xD;
          5. chronic opioid use&#xD;
&#xD;
          6. diseases affecting autoimmune system (immune disease, diabetic neuropathy)&#xD;
&#xD;
          7. use of medications affecting ANI monitor (antimuscarinics, alpha-agonist, beta&#xD;
             blocker)&#xD;
&#xD;
          8. illiteracy, foreigner&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jae Hoon Lee</last_name>
    <phone>82-10-2224-1055</phone>
    <email>neogens@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae Hoon Lee</last_name>
      <phone>82-10-2224-1055</phone>
      <email>neogens@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 9, 2020</study_first_submitted>
  <study_first_submitted_qc>April 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2020</study_first_posted>
  <last_update_submitted>November 7, 2021</last_update_submitted>
  <last_update_submitted_qc>November 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

